|
Apr 5
|
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
|
|
Nov 27
|
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
|
|
Sep 8
|
NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder
|
|
Sep 6
|
SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
|
|
Jun 30
|
NeuBase Announces Closing of $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
|
|
Jun 29
|
NeuBase Presents Non-Human Primate Data Illustrating Stealth Editors™ are Non-Immunogenic, Opening the Door to Redosing
|
|
Jun 28
|
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
|